Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Déjà vu? MHRA reviews kava

This article was originally published in The Tan Sheet

Executive Summary

The Medicines & Healthcare products Regulatory Agency will conduct a formal 12-week "public consultation exercise" in January 2005 to assess "whether the controls on kava kava remain justified and proportionate" and to "review the evidence relating to the hepatotoxicity" of the herbal, the UK health agency announces Aug. 11. The ban on kava in unlicensed herbal medicines took effect in January 2003 following reports of liver damage associated with the ingredient's consumption (1"The Tan Sheet" Jan. 6, 2003, In Brief). Health ministers who prohibited kava's sale requested the two-year follow-up. MHRA will formally write to interest groups for comment in January...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS097163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel